Drug Take-Back Act (HB1780) Summary

• Establishes a statewide drug take-back program requiring covered manufacturers to collect and dispose of unused, unwanted, and expired medicines through authorized collection sites operating year-round across Illinois counties.

• Drug manufacturers must register with the Environmental Protection Agency, pay $2,500 annual registration fees, and fund all administrative and operational costs of collection, transportation, and disposal of covered drugs.

• Requires at least one collection site per county with a potential authorized collector, plus one additional site per 50,000 county residents; manufacturers must negotiate in good faith with law enforcement agencies and other eligible collectors wanting to participate.

• Manufacturers must submit drug take-back program proposals to the EPA by July 1, 2023 for approval and begin operations by December 1, 2023; programs must include public education and outreach with a single toll-free number and website if multiple programs operate.

• Prohibits charging consumers point-of-sale or point-of-collection fees for drug take-back; pharmacies are not required to participate; violators face civil penalties of up to $7,000 per violation per day.